Abnormalities in biliary drainage may predict a better response to ursodeoxycholic acid in cystic fibrosis-associated liver disease.

被引：0
|
作者：
Colombo, C
Castellani, MR
Crosignani, A
Comi, S
Giunta, A
机构：
[1] UNIV SASSARI,DEPT PEDIAT,I-07100 SASSARI,ITALY
[2] UNIV MILAN,DEPT PEDIAT,I-20122 MILAN,ITALY
[3] UNIV MILAN,DEPT INTERNAL MED,I-20122 MILAN,ITALY
[4] IST NAZL TUMORI,DEPT NUCL MED,I-20133 MILAN,ITALY
来源：
HEPATOLOGY | 1996年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：298 / 298
页数：1
相关论文
共 50 条
  • [21] Ursodeoxycholic acid for cystic fibrosis-related liver disease
    Cheng, Katharine
    Ashby, Deborah
    Smyth, Rosalind L.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (12):
  • [22] Ursodeoxycholic acid and liver disease in an adult cystic fibrosis population
    Desmond, CP
    Roberts, SK
    GASTROENTEROLOGY, 2005, 128 (04) : A260 - A260
  • [23] EFFECTS OF URSODEOXYCHOLIC ACID THERAPY FOR LIVER-DISEASE ASSOCIATED WITH CYSTIC-FIBROSIS
    COLOMBO, C
    SETCHELL, KDR
    PODDA, M
    CROSIGNANI, A
    RODA, A
    CURCIO, L
    RONCHI, M
    GIUNTA, A
    JOURNAL OF PEDIATRICS, 1990, 117 (03): : 482 - 489
  • [24] URSODEOXYCHOLIC ACID THERAPY IN CYSTIC-FIBROSIS ASSOCIATED LIVER-DISEASE - A DOSE-RESPONSE STUDY
    COLOMBO, C
    CROSIGNANI, A
    ASSAISSO, M
    BATTEZZATI, PM
    PODDA, M
    GIUNTA, A
    ZIMMERNECHEMIAS, L
    SETCHELL, KDR
    HEPATOLOGY, 1992, 16 (04) : 924 - 930
  • [25] The effect of genetic modifiers on phenotypic variation in cystic fibrosis-associated pulmonary disease.
    Hilmer, SC
    Merlo, CA
    Enke, RA
    Couch, ME
    Hoffman, EP
    Garcia, JGN
    Boyle, MP
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 535 - 535
  • [26] A longitudinal assessment of non-invasive biomarkers to diagnose and predict cystic fibrosis-associated liver disease
    Karnsakul, Wikrom
    Wasuwanich, Paul
    Ingviya, Thammasin
    Vasilescu, Alexandra
    Carson, Kathryn A.
    Mogayzel, Peter J.
    Schwarz, Kathleen B.
    JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (04) : 546 - 552
  • [27] Cystic fibrosis-associated liver disease: A population-based study
    Corbett, K
    Kelleher, S
    Rowland, M
    Daly, L
    Drumm, B
    Canny, G
    Greally, P
    Hayes, R
    Bourke, B
    JOURNAL OF PEDIATRICS, 2004, 145 (03): : 327 - 332
  • [28] Response to Ursodeoxycholic Acid in Hispanic and Non-Hispanic Children with Cystic Fibrosis Liver Disease
    Fukushima, L. K.
    Woo, M. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [29] Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis
    Smith, JL
    Lewindon, PJ
    Hoskins, AC
    Pereira, TN
    Setchell, KDR
    O'Connell, NC
    Shepherd, RW
    Ramm, GA
    HEPATOLOGY, 2004, 39 (06) : 1673 - 1682
  • [30] Ursodeoxycholic Acid for Cystic Fibrosis Related Liver Disease, Our Experience
    G Mujtaba
    P Greally
    B Elnazir
    Pediatric Research, 2011, 70 : 534 - 534
12345